These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16988547)

  • 21. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
    Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
    Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
    Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease.
    Saibeni S; Vecchi M; Faioni EM; Franchi F; Rondonotti E; Borsi G; de Franchis R
    Dig Liver Dis; 2003 Jan; 35(1):32-6. PubMed ID: 12725605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
    Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
    Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
    Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
    J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.
    Balogh I; Szôke G; Kárpáti L; Wartiovaara U; Katona E; Komáromi I; Haramura G; Pfliegler G; Mikkola H; Muszbek L
    Blood; 2000 Oct; 96(7):2479-86. PubMed ID: 11001900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism.
    Corral J; González-Conejero R; Iniesta JA; Rivera J; Martínez C; Vicente V
    Haematologica; 2000 Mar; 85(3):293-7. PubMed ID: 10702819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhage.
    Parmeggiani F; Costagliola C; Incorvaia C; Gemmati D; D'Angelo S; Tognazzo S; Scapoli GL; Sebastiani A
    Am J Ophthalmol; 2004 Sep; 138(3):481-4. PubMed ID: 15364237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between the Val34Leu polymorphism in blood coagulation factor XIII-A and intracerebral hemorrhage: a meta-analysis.
    Ye X; Ye B
    Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.
    Shemirani AH; Antalfi B; Pongrácz E; Mezei ZA; Bereczky Z; Csiki Z
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):364-8. PubMed ID: 24686102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of FXIII-A Val34Leu polymorphism on coronary artery disease in Croatian patients.
    Bronić A; Ferencak G; Zadro R; Stavljenić-Rukavina A; Bernat R
    Mol Biol Rep; 2009 Jan; 36(1):1-5. PubMed ID: 17899444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population study.
    Boekholdt SM; Sandhu MS; Wareham NJ; Luben R; Reitsma PH; Khaw KT
    J Thromb Haemost; 2006 Oct; 4(10):2204-9. PubMed ID: 16881935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
    Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V
    J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Factor XIII-A subunit Val34Leu polymorphism and risk of venous thromboembolism in young adults].
    Demyanenko AV; Kapustin SI; Soroka VV; Chechulov PV
    Angiol Sosud Khir; 2015; 21(2):21-5. PubMed ID: 26035561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.
    Le Gal G; Delahousse B; Lacut K; Malaviolle V; Regina S; Blouch MT; Couturaud F; Mottier D; Oger E; Gruel Y;
    Thromb Res; 2007; 121(3):333-8. PubMed ID: 17568659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.
    Dossenbach-Glaninger A; van Trotsenburg M; Oberkanins C; Atamaniuk J
    J Clin Lab Anal; 2013 Nov; 27(6):444-9. PubMed ID: 24218126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
    Kattula S; Bagoly Z; Tóth NK; Muszbek L; Wolberg AS
    J Thromb Haemost; 2020 Apr; 18(4):885-894. PubMed ID: 31989767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency.
    Wilmer M; Rudin K; Kolde H; Poetzsch B; Lenz W; Moessmer G; Meili E; Egbring R; Gempeler-Messina P; Gempeler M; Bastian S; Kohler H
    Thromb Res; 2001 Apr; 102(1):81-91. PubMed ID: 11323018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor XIII--circulating levels and Val34Leu polymorphism in relatives of South Asian patients with ischemic stroke.
    Kain K; Bamford J; Bavington J; Young J; Catto AJ
    J Thromb Haemost; 2005 Jan; 3(1):171-3. PubMed ID: 15634282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.